X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (9) 9
female (9) 9
humans (9) 9
index medicus (8) 8
male (8) 8
middle aged (7) 7
drug therapy (6) 6
infectious diseases (6) 6
aged (5) 5
hiv infections - drug therapy (5) 5
hiv infections - virology (5) 5
hiv infection (4) 4
infectious disease (4) 4
antiviral agents (3) 3
dosage and administration (3) 3
drug therapy, combination (3) 3
elvitegravir (3) 3
hiv-1 - drug effects (3) 3
immunology (3) 3
microbiology (3) 3
adenine - analogs & derivatives (2) 2
adenine - therapeutic use (2) 2
adults (2) 2
aids-related opportunistic infections - microbiology (2) 2
aids-related opportunistic infections - prevention & control (2) 2
aids/hiv (2) 2
anti-bacterial agents - therapeutic use (2) 2
anti-hiv agents - therapeutic use (2) 2
antiretroviral therapy (2) 2
bacteremia (2) 2
bacteremia - mortality (2) 2
clinical trials (2) 2
cobicistat (2) 2
combination therapy (2) 2
comparative analysis (2) 2
disease (2) 2
double-blind method (2) 2
efficacy (2) 2
emtricitabine (2) 2
emtricitabine - therapeutic use (2) 2
health aspects (2) 2
hiv infections - immunology (2) 2
hiv patients (2) 2
hiv protease inhibitors - therapeutic use (2) 2
hiv-1 - immunology (2) 2
hiv-1 - physiology (2) 2
human immunodeficiency virus--hiv (2) 2
immunodeficiency (2) 2
infections (2) 2
integrase inhibitor (2) 2
mycobacterium avium complex (2) 2
mycobacterium avium-intracellulare infection - prevention & control (2) 2
open-label (2) 2
patient outcomes (2) 2
patients (2) 2
prospective studies (2) 2
public health (2) 2
raltegravir potassium (2) 2
rilpivirine (2) 2
rilpivirine - therapeutic use (2) 2
ritonavir - therapeutic use (2) 2
rna, viral - blood (2) 2
tenofovir (2) 2
tenofovir - therapeutic use (2) 2
treatment outcome (2) 2
treatment-naive (2) 2
trial (2) 2
viral load (2) 2
young adult (2) 2
2 controlled trials (1) 1
873140 (1) 1
[ sdv ] life sciences [q-bio] (1) 1
[sdv]life sciences [q-bio] (1) 1
abridged index medicus (1) 1
abstract supplement (1) 1
acquired immune deficiency syndrome--aids (1) 1
acquired immunodeficiency syndrome - complications (1) 1
acquired immunodeficiency syndrome - microbiology (1) 1
acquired immunodeficiency syndrome - mortality (1) 1
activity inference (1) 1
activity-based applications (1) 1
adipose tissue - pathology (1) 1
adverse events (1) 1
aids (1) 1
aids-related opportunistic infections - epidemiology (1) 1
aids-related opportunistic infections - mortality (1) 1
alanine transaminase - blood (1) 1
algorithms, caches (1) 1
alkaline phosphatase (1) 1
ambient display (1) 1
anti-bacterial agents - adverse effects (1) 1
anti-hiv agents (1) 1
anti-hiv agents - administration & dosage (1) 1
anti-hiv agents - adverse effects (1) 1
anti-hiv agents - pharmacology (1) 1
anti-retroviral agents - adverse effects (1) 1
anti-retroviral agents - therapeutic use (1) 1
antiretroviral therapy, highly active - methods (1) 1
aplaviroc (1) 1
aplaviroc; 873140 (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 1, pp. 27 - 35
Summary Background Elvitegravir is a once daily inhibitor of HIV-1 integrase boosted by ritonavir. We aimed to compare the efficacy and safety of elvitegravir... 
Infectious Disease | INFECTIOUS DISEASES | DARUNAVIR-RITONAVIR | TREATMENT-NAIVE | DOSE-RESPONSE | COMBINATION THERAPY | TMC125 ETRAVIRINE | HIV-1-INFECTED PATIENTS | INFECTION | PLACEBO-CONTROLLED TRIAL | INTEGRASE INHIBITOR | SUBGROUP | Humans | Middle Aged | Male | RNA, Viral - blood | Alanine Transaminase - blood | Diarrhea - chemically induced | Viral Load | Oligopeptides - therapeutic use | Pyrrolidinones - administration & dosage | HIV Infections - immunology | Drug Therapy, Combination - adverse effects | Quinolones - adverse effects | Quinolones - therapeutic use | Atazanavir Sulfate | Ritonavir - therapeutic use | Adult | Female | Raltegravir Potassium | Pyridines - therapeutic use | Anti-Retroviral Agents - therapeutic use | Pyrrolidinones - adverse effects | Double-Blind Method | HIV Infections - virology | Anti-Retroviral Agents - adverse effects | Pyrrolidinones - therapeutic use | Treatment Outcome | CD4 Lymphocyte Count | HIV Protease Inhibitors - therapeutic use | HIV-1 - immunology | Quinolones - administration & dosage | Aspartate Aminotransferases - blood | HIV Integrase Inhibitors - therapeutic use | HIV Infections - drug therapy | Lopinavir - therapeutic use | Antiviral agents | Medical research | Protease inhibitors | Proteases | Medicine, Experimental | HIV patients | HIV (Viruses) | Anti-HIV agents
Journal Article
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its... 
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Journal Article
Genetics in Medicine, ISSN 1098-3600, 06/2018, Volume 20, Issue 6, pp. 608 - 613
Purpose: To determine feasibility and utility of newborn screening for spinal muscular atrophy (SMA) in New York State. Methods: We validated a multiplex... 
GENE | SMA | GENETICS & HEREDITY | nusinersen | spinal muscular atrophy | SMN1 | IDENTIFICATION | newborn screening | PCR | Medical screening
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2013, Volume 207, Issue 5, pp. 740 - 748
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 10/2016, Volume 19, Issue 8(Suppl 7), pp. 21487 - n/a
Journal Article
AIDS Research and Therapy, ISSN 1742-6405, 04/2009, Volume 6, Issue 1, pp. 3 - 3
Traditional first line regimens containing a non-nucleoside reverse transcriptase inhibitor or protease inhibitor may not be suitable for a subset of... 
Antiviral agents | Dosage and administration | Diagnosis | Research | Comparative analysis | Drug therapy | HIV infection
Journal Article